MedTrace Logo

MISSION COPD - Modern Innovative SolutionS in Improving Outcomes iN COPD

NCT02534766 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 114

Last updated 2016-09-27

No results posted yet for this study

Summary

MISSION is a new and novel way of delivering highly specialised Chronic Obstructive Pulmonary Disease (COPD) care and has the potential to change the way COPD care across the UK is delivered as well as services for other long term health conditions. The MISSION model has been piloted in asthma which is the subject of an ongoing research study. This is the first model of this type in COPD and the current research study aims to evaluate the outcomes of the project. This will be done in several different ways. The study is a mixed methods evaluation of the new service comparing outcomes before and after the clinic using retrospective data analysis and prospective qualitative interview. The study will be conducted at Portsmouth Hospitals NHS Trust and will recruit patients who attend MISSION COPD clinics as well as staff who attended MISSION clinics in a professional capacity.

Conditions

  • Pulmonary Disease, Chronic Obstructive

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Portsmouth Hospitals NHS Trust

    lead OTHER_GOV

Principal Investigators

  • Professor Anoop J Chauhan · Portsmouth Hospitals NHS Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-08-31
Completion
2016-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02534766 on ClinicalTrials.gov